Choline, mainly used to study parathyroid disease, and PSMA, to diagnose and monitor prostate cancer, are already routinely used in clinical practice, possibly increasing their chances of being implemented in ovarian cancer diagnostics. The gene discussed is FOLH1; the disease is ovarian carcinoma.